 severity. Such
a properly stratiﬁed, three-dimensional matrix would lead
to improved clinical trial designs73 and ultimately better
evidence-based care for patients with chronic lower
extremity ischemia and/or tissue compromise.
Finally, attention should be directed toward redeﬁning
outcomes. Patency, limb salvage, and amputation-free
survival are not the only criteria for success. The SVS has
initiated this process with the publication of objective performance goals